IP Library Granted Patent US 12,397,158
Granted Patent B2
US 12,397,158 · App. 17/753,374 · Granted Aug 26, 2025

System for locally activating the human eye and the brain in order to train visual performance, in particular in order to activate the visual cortex and reorganized neural networks in the human brain in order to strengthen residual vision

Inventors: Ying Gao (Magdeburg, DE); Kornelia Sabel (Berlin, DE)
Assignee: SAVIR GMBH
A61N1/36046A61N1/0456A61N1/0472A61N1/36031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,397,158
App. No.
17/753,374
Granted
Aug 26, 2025
Kind
B2
Abstract

The invention relates to a system for locally activating the nervous system in the human eye and in the brain by means of a non-invasive pulse treatment in order to strengthen residual vision in cases of existing visual field defects, consisting of an applicator for guiding a flow of current to the eye and/or brain and to excite the circulation and activate nerve cells, in particular nerve cells of the visual system and retinal ganglion cells, a pulse generator for generating electric stimulation signals, and a data processing and control unit for providing patient-specific stimulation signal sequences, wherein the applicator has at least two electrodes which can be brought into contact with the head of the subject. Replaceable stimulation electrodes are fixed to the applicator such that the electrodes rest to the right and to the left of the eye in the region of the temple of the patient's head. The applicator additionally has at least one assembly for non-invasively determining the circulation of the skin and the brain and for determining the oxygen saturation in order to improve the stimulation effect in this regard when using the system.

Claims (69)

1. A system for locally activating nerve cells in a human eye and a human brain of a patient by means of a non-invasive pulse treatment in order to strengthen residual vision in cases of visual field defects, the system comprising:

an applicator for guiding a flow of current to the eye and/or brain and to excite circulation and activate the nerve cells,

a pulse generator for generating electric stimulation signals,

a memory in which patient-specific stimulation signal sequences are stored,

a data processor, the data processor being in electrical communication with the memory, a pulse generator controller, the pulse generator controller being in electrical communication with the data processor and the pulse generator, the pulse generator controller being configured to provide the patient-specific stimulation signal sequences to the pulse generator, and

a unit for determining contact resistance between the stimulation electrodes and a skin surface of the patient in order to shut off the pulse generator, the unit having electronic circuitry that is in electrical communication with the stimulation electrodes,

wherein the applicator has at least two stimulation electrodes which are configured to be placed in contact with a head of the patient,

wherein

the stimulation electrodes are fixed to the applicator and configured to be placed in contact with or rest against a temple region of the patient's head to the right and to the left of an eye of the patient.

2. The system according to claim 1 ,

characterized in that

the applicator is individually adaptable to a shape of the patient's head and adjusting means are formed with respect to being fixed to forehead and rear head regions of the patient.

3. The system according to claim 1 ,

characterized in that

the applicator is formed as a ring-shaped or crown-shaped structure that can be mounted on the head, wherein a nasal bridge support and/or an ear support and/or a rear head support and a receptacle for electronic components und for weight compensation in the rear head region are provided.

4. The system according to claim 3 ,

characterized in that

the electronic components have a current supply.

5. The system according to claim 4 , wherein the current supply is a battery or an accumulator.

6. The system according to claim 1 ,

characterized in that

the stimulation electrodes are formed as dry pad electrodes or wet pad electrodes.

7. The system according to claim 1 ,

characterized in that

on the applicator, fixing points for attaching further electrodes are provided enabling alternating current application in the region below the patient's eyes.

8. The system according to claim 1 ,

characterized in that

on or in the applicator, an interface for wired or wireless data transmission is formed.

9. The system according to claim 1 ,

characterized in that

sound generating means are provided on the applicator, so as to guide the patient by information during the treatment and/or to relax him acoustically.

10. The system according to claim 1 ,

characterized in that

the pulse generator is an alternating current pulse generator which generates alternating current pulses, and

for self-sufficient operation, the applicator comprises each of the alternating current pulse generator, the data processor and the pulse generator controller together with a current supply, wherein the treatment process and/or the stimulation signal sequence is/are realizable by a computer program product.

11. The system according to claim 1 ,

characterized in that

on or in the applicator, a moisture reservoir is provided for wetting the stimulation electrodes.

12. The system according to claim 1 ,

characterized in that

the applicator and/or holders for receiving the stimulation electrodes are formed of a deformable plastic material.

13. The system according to claim 1 ,

characterized in that

the holders and/or the stimulation electrodes are formed of a conductive plastic material.

14. The system according to claim 1 ,

characterized in that

a bag for receiving stimulation electrodes is present on the applicator.

15. The system according to claim 1 ,

characterized in that

the applicator is formed to be combinable for combination with an EEG electrode cap known as such.

16. The system according to claim 1 ,

characterized in that

the applicator has at least one assembly for non-invasively determining circulation of the skin and the brain and for determining oxygen saturation, wherein an NIR emitter and at least one associated NIR detector are positionable at a position spaced from the stimulation electrodes on the patient's head and separately from the stimulation electrodes, and NIR spectroscopy data is detected in breaks or at an end of stimulation signal sequences so as to determine a temporal duration of a persisting improved blood circulation and/or oxygen saturation so that consequently an updated operating of the data processor and the pulse generator controller may be realized.

17. The system according to claim 1 ,

characterized in that

the position of the stimulation electrodes corresponds to an F7-F8 arrangement according to the nomenclature of the EEG 10-20 system.

18. The system according to claim 1 , wherein the nerve cells in the human eye and the human brain are activated by means of a non-invasive alternating current pulse treatment (tASC).

19. The system according to claim 1 , wherein the nerve cells are retinal ganglion cells.

20. The system according to claim 1 , wherein the stimulation electrodes are replaceable.

21. The system according to claim 1 ,

characterized in that

on the applicator, fixing points for clipping on further electrodes are provided enabling alternating current application also in a region below the patient's eyes.

22. The system according to claim 1 ,

characterized in that

sound generating means formed as earphones or headphones are provided on the applicator, so as to guide the patient by information during the treatment and/or to relax him acoustically.

23. The system according to claim 1 ,

characterized in that

the applicator has at least one assembly for non-invasively determining circulation of the skin and the brain and for determining oxygen saturation on the basis of fNIR spectroscopy,

wherein an NIR emitter and at least one associated NIR detector are positionable at a position spaced from the stimulation electrodes on the patient's head and separately from the stimulation electrodes, and NIR spectroscopy data is detected in breaks or at an end of stimulation signal sequences so as to determine a temporal duration of a persisting improved blood circulation and/or oxygen saturation so that consequently an updated operating of the data processor and the pulse generator controller may be realized.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2022
From: GAO, YING; SABEL, KORNELIA
To: SAVIR GMBH
Reel/Frame 060924/0318 →
Priority Claims (4)
DE 102019125416.7 · Sep 20, 2019 · national
DE 102019126163.5 · Sep 27, 2019 · national
DE 102019127098.7 · Oct 9, 2019 · national
DE 102019130302.8 · Nov 11, 2019 · national
Continuity (1)
Related Publication 20220314000A1 · Oct 6, 2022
References Cited (30)
US 5522864A · Wallace et al. · 1996 [cited by applicant]
US 9566427B2 · Wagner · 2017 [cited by applicant]
US 10391312B2 · Mowery et al. · 2019 [cited by applicant]
US 20060129207A1 · Fried et al. · 2006 [cited by applicant]
CN 1065392A · 1992 [cited by applicant]
CN 109045435A · 2018 [cited by examiner]
DE 102011055844B4 · 2014 [cited by applicant]
EP 1332771A2 · 2003 [cited by examiner]
EP 1708787B1 · 2011 [cited by applicant]
EP 1603633B1 · 2012 [cited by applicant]
EP 2651504B1 · 2014 [cited by applicant]
EP 1734877B1 · 2015 [cited by applicant]
EP 2981326B1 · 2018 [cited by applicant]
EP 3349844A1 · 2018 [cited by applicant]
EP 3013414B1 · 2018 [cited by applicant]
EP 3598962A1 · 2020 [cited by applicant]
EP 3349844B1 · 2021 [cited by applicant]
JP H0975465A · 1997 [cited by applicant]
WO WO2011106660A1 · 2011 [cited by applicant]
WO WO2013037618A1 · 2013 [cited by applicant]
WO WO2014141213A1 · 2014 [cited by applicant]
WO WO2016115392A1 · 2016 [cited by applicant]
WO WO2017048731A1 · 2017 [cited by applicant]
WO WO2017222997A1 · 2017 [cited by examiner]
Gall, et al., “ [cited by applicant]
The Notification Concerning Transmittal of International Preliminary Report on Patentability (Chapter I of the Patent Cooperation Treaty), in English, dated Mar. 31, 2022, which was issued by the International Bureau of… [cited by applicant]
The English translation of the International Preliminary Report on Patentability (Chapter I of the Patent Cooperation Treaty), dated Mar. 15, 2022, which was issued by the International Bureau of WIPO in Applicant's cor… [cited by applicant]
The Written Opinion of the International Searching Authority, in English, dated Nov. 26, 2020, which was issued by the International Bureau of WIPO in Applicant's corresponding international PCT application having Seria… [cited by applicant]
The International Search Report, in English, dated Nov. 26, 2020, which was issued by the International Bureau of WIPO in Applicant's corresponding international PCT application having Serial No. PCT/EP2020/074408, file… [cited by applicant]
An Office Action (in German), dated Jul. 15, 2020, issued by the German Patent Office for Applicant's corresponding German Patent Application No. DE102019130302.8, filed Nov. 11, 2019. [cited by applicant]